31 results match your criteria: "Furukawa Seiryo Hospital[Affiliation]"
Acta Neurochir (Wien)
August 2023
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Only two aneurysm formations in the internal carotid artery after gamma knife radiosurgery (GKRS) for pituitary adenomas are reported so far. Here, out of the 482 patients who underwent GKRS for pituitary adenomas at our institute, at least five developed aneurysms within the area of high single-dose irradiation. Three patients presented with epistaxis due to aneurysmal rupture and one presented with abducens paralysis due to nerve compression, while one was asymptomatic.
View Article and Find Full Text PDFNeurosurgery
October 2023
Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore, Singapore.
Background: The hemorrhage risk of unruptured and untreated cerebral arteriovenous malformations (AVMs) has been shown to be higher for female patients than male patients in their child bearing ages. Although it has been neurosurgical practice to advise female patients in their childbearing ages to postpone pregnancy until proven AVM obliteration, there is no literature consensus regarding this potential hemorrhage risk increase.
Objective: To accurately quantify the risk increase for AVM hemorrhage during pregnancy.
J Neurosurg
July 2023
4Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai.
Objective: Gamma Knife radiosurgery (GKRS) is a powerful tool for the management of arteriovenous malformations; however, newly formed mass lesions resembling cavernous malformations are a rare late complication of GKRS. In this retrospective study, the authors tried to clarify the unique histological features of these mass lesions.
Methods: The authors retrospectively reviewed the clinical course of 889 patients who had undergone GKRS for arteriovenous malformations at their institute from 1991 to 2021.
World Neurosurg
March 2023
Department of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Objective: A retrospective comparative analysis of the outcomes of gamma knife radiosurgery (GKRS) for brain metastases from uterine cervical carcinoma (CC) and endometrial carcinoma (EC), investigated the efficacy and prognostic factors for survival and local tumor control. Histopathological analysis was also performed.
Methods: The authors retrospectively reviewed 61 patients with 260 tumors of CC and 73 patients with 302 tumors of EC who had undergone GKRS.
Neurosurgery
December 2022
Department of Hospitals Physics, Karolinska University Hospital, Stockholm, Sweden.
Background: Knowledge about the natural course of brain arteriovenous malformations (AVMs) have increased during the past 20 years, as has the number of AVMs treated, especially larger ones. It is thus timely to again analyze the risk for hemorrhage after Gamma Knife Surgery (GKS).
Objective: To confirm or contradict conclusions drawn 20 years ago regarding factors that affect the risk for post-GKS hemorrhage.
J Stroke
May 2022
Department of Neurosurgery, The University of Tokyo Hospital, Tokyo, Japan.
Background And Purpose: To assess the long-term outcomes of intracranial dural arteriovenous fistula (DAVF) treated with stereotactic radiosurgery (SRS) alone or embolization and SRS (Emb-SRS) and to develop a grading system for predicting DAVF obliteration.
Methods: This multi-institutional retrospective study included 200 patients with DAVF treated with SRS or Emb-SRS. We investigated the long-term obliteration rate and obliteration-associated factors.
J Neurosurg
October 2022
1Department of Neurosurgery, The University of Tokyo Hospital, Tokyo.
Objective: Radiotherapy has an essential role in the management of skull base chondrosarcomas (SBCs) after resection. This multi-institutional study evaluated the outcomes of Gamma Knife radiosurgery (GKRS) for histopathologically proven SBCs.
Methods: Data of patients who underwent GKRS for SBCs at Gamma Knife centers in Japan were retrospectively collected.
J Neurosurg
October 2022
12Department of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Objective: Brain metastasis is rare in ovarian cancer patients. The results of Gamma Knife radiosurgery (GKRS) for the treatment of patients with brain metastases from ovarian cancer were retrospectively analyzed to derive the efficacy and prognostic factors for survival and local tumor control. Further histopathological analysis was also performed.
View Article and Find Full Text PDFClin Transl Radiat Oncol
January 2022
Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
Background And Purpose: The Renal Graded Prognostic Assessment (GPA) is relatively new and has not been sufficiently validated using a different dataset. We thus developed a new grading index, the Renal Brain Metastasis Score (Renal-BMS).
Materials And Methods: Using our dataset including 262 renal cancer patients with brain metastases (BMs) undergoing stereotactic radiosurgery (SRS) (test series), we validity tested the Renal-GPA.
BMC Neurol
May 2021
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Background: Treating chordoma through surgery alone is often ineffective. Thus, surgery often performed with irradiation, with a reported 5-year survival rate of 60-75%. The clinical course varies, and disease rarity prevents larger number of clinical investigations.
View Article and Find Full Text PDFBackground/aim: The problem of lack of standardisation in target delineation and herewith the variability of target contours in Gamma Knife radiosurgery is as severe as in linac-based radiotherapy in general. The first aim of this study was to quantify the contouring variability for a group of five radiosurgery targets and estimate their true-volume based on multiple delineations using the Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm. The second aim was to assess the robustness of the STAPLE method for the assessment of the true-volume, with respect to the number of contours available as input.
View Article and Find Full Text PDFBreast Cancer Res Treat
November 2020
Department of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Introduction: Brain metastasis (BM) is one of the most important issues in the management of breast cancer (BC), since BMs are associated with neurological deficits. However, the importance of BC subtypes remains unclear for BM treated with Gamma Knife radiosurgery (GKS). Thus, we conducted a multicenter retrospective study to compare clinical outcomes based on BC subtypes, with the aim of developing an optimal treatment strategy.
View Article and Find Full Text PDFActa Neurochir (Wien)
July 2020
Department of Surgery, Div. of Neurosurgery, National University Hospital, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore.
Background: A significant difference exists between the published results reporting the clinical outcome following brain arteriovenous malformation (AVM) ruptures. Information about the outcome following hemorrhage in an AVM population treated with radiosurgery could provide additional information to assess the risk of mortality and morbidity following an AVM hemorrhage.
Methods: Clinical outcome was studied in 383 patients, the largest patient population yet studied, who suffered from a symptomatic hemorrhage after Gamma Knife® surgery (GKS) but before confirmed AVM obliteration.
J Neurooncol
March 2020
Department of Human Health Sciences, School of Medicine, Kyoto University, Kyoto, Japan.
Purpose: To evaluate the efficacy of gamma knife radiosurgery (GKS) for brain metastases (BMs) from small-cell lung cancer after whole-brain radiotherapy (WBRT).
Methods: We retrospectively analyzed the usefulness and safety of GKS in 163 patients from 15 institutions with 1-10 active BMs after WBRT. The usefulness and safety of GKS were evaluated using statistical methods.
J Neurooncol
October 2019
Department of Radiology, Niigata University Graduate School of Medicine and Dental Sciences, Niigata, Japan.
Purpose: Recent advances in targeted therapy have prolonged overall survival (OS) for patients with lung cancer. The impact of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI) on brain metastases (BM) treated with stereotactic radiosurgery (SRS) has not, however, been fully elucidated. We investigated the influence of post-SRS EGFR-TKI use on the efficacy and toxicity of SRS for BM from lung adenocarcinoma.
View Article and Find Full Text PDFJ Neurooncol
September 2019
Department of Radiology, Niigata University Graduate School of Medicine and Dental Sciences, Niigata, Japan.
Purpose: Stereotactic radiosurgery (SRS) has been increasingly used for elderly patients with brain metastases (BMs). However, no studies based on a large sample size have been reported. To compare SRS treatment results between elderly and non-elderly patients, we performed a subset study of elderly patients using our prospectively-accumulated multi-institution study database (JLGK0901 Study, Lancet Oncol 15:387-395, 2014).
View Article and Find Full Text PDFJ Neurosurg
May 2020
10Department of Neurosurgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Objective: The Japanese Leksell Gamma Knife (JLGK)0901 study proved the efficacy of Gamma Knife radiosurgery (GKRS) in patients with 5-10 brain metastases (BMs) as compared to those with 2-4, showing noninferiority in overall survival and other secondary endpoints. However, the difference in local tumor progression between patients with 2-4 and those with 5-10 BMs has not been sufficiently examined for this data set. Thus, the authors reappraised this issue, employing the updated JLGK0901 data set with detailed observation via enhanced MRI.
View Article and Find Full Text PDFJ Neurosurg
December 2018
1Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore.
OBJECTIVEThere is a strong clinical need to accurately determine the average annual hemorrhage risk in unruptured brain arteriovenous malformations (AVMs). This need motivated the present initiative to use data from a uniquely large patient population and design a novel methodology to achieve a risk determination with unprecedented accuracy. The authors also aimed to determine the impact of sex, pregnancy, AVM volume, and location on the risk for AVM rupture.
View Article and Find Full Text PDFJ Neurosurg
December 2018
11Department of Radiology, Niigata University Graduate School of Medicine and Dental Sciences, Niigata, Japan.
OBJECTIVEPrevious Japanese Leksell Gamma Knife Society studies (JLGK0901) demonstrated the noninferiority of stereotactic radiosurgery (SRS) alone as the initial treatment for patients with 5-10 brain metastases (BMs) compared with those with 2-4 BMs in terms of overall survival and most secondary endpoints. The authors studied the aforementioned treatment outcomes in a subset of patients with BMs from non-small cell lung cancer (NSCLC).METHODSPatients with initially diagnosed BMs treated with SRS alone were enrolled in this prospective observational study.
View Article and Find Full Text PDFNeurosurgery
July 2019
Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore, Singapore.
Background: The optimal management of unruptured brain arteriovenous malformations (AVMs) is controversial after the ARUBA trial.
Objective: To confirm or repudiate the ARUBA conclusion that "medical management only is superior to medical management with interventional therapy for unruptured brain arteriovenous malformations."
Methods: Data were collected from 1351 patients treated with Gamma Knife Surgery (GKS; Elekta AB, Stockholm, Sweden) for unruptured and untreated AVMs The follow-up was 8817 yr (median 5.
J Clin Oncol
June 2018
Takamasa Kayama, Shinya Sato, Kaori Sakurada, Yukihiko Sonoda, Yamagata University Faculty of Medicine, Yamagata; Junki Mizusawa, Yoshitaka Narita, Yasuji Miyakita, Hiroshi Katayama, Haruhiko Fukuda, Soichiro Shibui, National Cancer Center Hospital; Minako Sumi, Cancer Institute Hospital; Akitake Mukasa, The University of Tokyo Graduate School of Medicine; Yoshihiro Muragaki, Motohiro Hayashi, Tokyo Women's Medical University; Takao Watanabe, Nihon University School of Medicine; Hikaru Sasaki, Keio University School of Medicine; Masao Tago, Teikyo University Mizonokuchi Hospital; Motoo Nagane, Kyorin University Faculty of Medicine, Tokyo; Ryo Nishikawa, Saitama Medical University International Medical Center, Saitama; Toshihiro Kumabe, Tohoku University Graduate School of Medicine; Eiji Shimizu, Tohoku University Hospital; Hidefumi Jokura, Furukawa Seiryo Hospital, Miyagi; Yoshiki Arakawa, Susumu Miyamoto, Takashi Mizowaki, Kyoto University Graduate School of Medicine, Kyoto; Takaaki Beppu, Iwate Medical University, Morioka; Kazuhiko Sugiyama, Hiroshima University Hospital, Hiroshima; Hirohiko Nakamura, Nakamura Memorial Hospital, Sapporo; Yoko Nakasu, Shizuoka Cancer Center, Shizuoka; Naoya Hashimoto, Osaka University Graduate School of Medicine; Manabu Kinoshita, Osaka International Cancer Institute; Akio Asai, Kansai Medical University; Koichi Iwasaki, Kitano Hospital; Tomokazu Aoki, Kitano Medical Research Institute and Hospital, Osaka; Mizuhiko Terasaki, Kurume University, Kurume; Akira Matsumura, Eiichi Ishikawa, University of Tsukuba, Tsukuba; Toshihiko Wakabayashi, Nagoya University, Nagoya; Yasuo Iwadate, Chiba University, Chiba; Shiro Ohue, Ehime University Graduate School of Medicine, Ehime; Hiroyuki Kobayashi, Hiroki Shirato, Hokkaido University Graduate School of Medicine, Hokkaido; Kenichiro Asano, Hirosaki University Graduate School of Medicine, Hirosaki City; Katsuyuki Tanaka, St Marianna University School of Medicine, Kanagawa; Hideo Nakamura, Kumamoto University, Kumamoto; Tatsuya Abe, Oita University Faculty of Medicine, Oita; Shuichi Izumoto, Hyogo College of Medicine, Hyogo; Masahiro Mizoguchi, Kyushu University, Fukuoka; Takayuki Matsuo, Nagasaki Graduate School of Biomedical Sciences, Nagasaki; and Hideo Takeshima, University of Miyazaki, Miyazaki, Japan.
Purpose Whereas whole-brain radiotherapy (WBRT) has been the standard treatment of brain metastases (BMs), stereotactic radiosurgery (SRS) is increasingly preferred to avoid cognitive dysfunction; however, it has not been clearly determined whether treatment with SRS is as effective as that with WBRT or WBRT plus SRS. We thus assessed the noninferiority of salvage SRS to WBRT in patients with BMs. Patients and Methods Patients age 20 to 79 years old with performance status scores of 0 to 2-and 3 if caused only by neurologic deficits-and with four or fewer surgically resected BMs with only one lesion > 3 cm in diameter were eligible.
View Article and Find Full Text PDFActa Oncol
November 2018
a Medical Radiation Physics, Department of Physics , Stockholm University, Stockholm , Sweden.
Background: Although accurate delineation of the target is a key factor of success in radiosurgery there are no consensus guidelines for target contouring.
Aim: The aim of the present study was therefore to quantify the variability in target delineation and discuss the potential clinical implications, for six targets regarded as common in stereotactic radiosurgery.
Material And Methods: Twelve Gamma Knife centers participated in the study by contouring the targets and organs at risks and performing the treatment plans.
J Neurooncol
May 2018
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Pituitary adenomas with high proliferation rate and rapid growth are well known, but the clinical characteristics, prognosis, and treatment algorithm remain unclear. The clinical characteristics and mid-term prognosis of patients with non-functioning pituitary adenomas with high proliferative potential were retrospectively investigated. This study identified 53 patients with Ki-67 labeling index of > 3% among 845 patients with non-functioning pituitary adenoma (6.
View Article and Find Full Text PDFWorld Neurosurg
May 2018
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Objective: The purpose of this study was to clarify clinical features, outcomes, and the role of tumor resection in precocious, synchronous, and metachronous brain metastases.
Methods: Brain metastases were found before primary cancer detection in the precocious group, within 2 months after primary cancer detection in the synchronous group, and 2 months or later after primary cancer detection in the metachronous group.
Results: Of 471 patients with brain metastases, 93 (20%) were included in the precocious group, 76 (16%) in the synchronous group, and 302 (64%) in the metachronous group.
Int J Radiat Oncol Biol Phys
September 2017
Department of Radiology, Niigata University Graduate School of Medicine and Dental Sciences, Niigata, Japan.
Purpose: The JLGK0901 study showed the noninferiority of stereotactic radiosurgery (SRS) alone as initial treatment of 5 to 10 brain metastases (BMs) compared with 2 to 4 BMs in terms of overall survival and most secondary endpoints (Lancet Oncol 2014;15:387-95). However, observation periods were not long enough to allow confirmation of the long-term safety of SRS alone in patients with 5 to 10 BMs.
Methods And Materials: This was a prospective observational study of Gamma Knife SRS-treated patients with 1 to 10 newly diagnosed BMs enrolled at 23 facilities between March 1, 2009, and February 15, 2012.